# US 2019/0054015 A1 · Temperature sensitive hydrogel composition including nucleic acid and chitosan

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0054015 A1
- Document ID: US20190054015A1
- Status: Published application
- Kind: A1
- Application number: 16/075,296
- Filed: 2016-02-29
- Published: 2019-02-21
- Earliest claimed: 2016-02-05
- Assignees: Pharmaresearch Products Co., Ltd.
- Applicants: Pharmaresearch Products Co., Ltd.
- Inventors: Ik Soo KIM; Han Gyu KIM; Cheol Am HONG; Su Yeon LEE
- Web page: https://patentgrep.com/patent/US20190054015A1

## CPC

- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- C08J 3/075: Macromolecular gels
- C08L 5/00: Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08J 2305/00: Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J 2305/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C08J 2377/04: Polyamides derived from alpha-amino carboxylic acids (C08J2377/10 takes precedence)
- C08J 2405/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention provides a temperature sensitive hydrogel composition including a nucleic acid and chitosan. Since the hydrogel has excellent biocompatibility and biostability, and simultaneously has sol-gel phase transition properties depending on temperature changes, the hydrogel is present in a sol state at room temperature and becomes a gel when the hydrogel is injected into the human body or applied on the surface of epithelial skin and the temperature increases. Thus, the temperature-sensitive hydrogel of the present invention can be directly injected into and applied on certain parts requiring treatment and the retention and attaching time of a drug is increased through gelation depending on the temperature so that drug efficacy is sufficiently exhibited. Therefore, it is expected that the temperature-sensitive hydrogel of the present invention can be utilized for various treatments.

## Claims

### Claim 1

A temperature-sensitive hydrogel composition containing a nucleic acid and chitosan, wherein the weight ratio of the nucleic acid and the chitosan is 20:1 to 10000:1.

### Claim 2 (depends on 1)

The temperature-sensitive hydrogel composition of claim 1, wherein the weight ratio of the nucleic acid and the chitosan is 50:1 to 2000:1.

### Claim 3 (depends on 2)

The temperature-sensitive hydrogel composition of claim 2, wherein the weight ratio of the nucleic acid and the chitosan is 100:1 to 1000:1.

### Claim 4 (depends on 1)

The temperature-sensitive hydrogel composition of claim 1, wherein the content of the nucleic acid is 0.01 wt % to 3 wt % relative to the total weight of the composition.

### Claim 5 (depends on 4)

The temperature-sensitive hydrogel composition of claim 4, wherein the nucleic acid is deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or a mixture thereof.

### Claim 6 (depends on 1)

The temperature-sensitive hydrogel composition of claim 1, wherein the content of the chitosan is 1×10−6 wt % to 0.15 wt % relative to the total weight of the composition.

### Claim 7 (depends on 6)

The temperature-sensitive hydrogel composition of claim 6, wherein the molecular weight of the chitosan is 3 kDa to 1,000 kDa.

### Claim 8 (depends on 1)

The temperature-sensitive hydrogel composition of claim 1, wherein the temperature-sensitive hydrogel composition contains a polymer material as an additional ingredient.

### Claim 9 (depends on 8)

The temperature-sensitive hydrogel composition of claim 8, wherein the polymer material is at least one selected from the group consisting of hyaluronic acid, poly-Y-glutamic acid, cellulose, polyacrylic acid, polyamino acids, alginate, and derivatives and a combination thereof.

### Claim 10 (depends on 1)

A method for producing the temperature-sensitive hydrogel composition of claim 1, the method comprising:
i) preparing a nucleic acid stock solution;
ii) preparing a chitosan stock solution;
iii) mixing the nucleic acid stock solution in step i) and the chitosan stock solution in step ii) such that the weight ratio of a nucleic acid and chitosan is 20:1 to 10000:1, followed by stirring; and
iv) lowering the nucleic acid-chitosan mixture liquid in step iii) to room temperature with stirring.

### Claim 11 (depends on 10)

The method of claim 10, the method comprising:
i) putting a nucleic acid in a buffer solution, and dissolving the nucleic acid in the buffer solution for 1-2 hours with stirring at 60-70° C., to prepare a nucleic acid stock solution;
ii) dissolving chitosan in an acidic buffer solution to prepare a chitosan stock solution;
iii) mixing the nucleic acid stock solution in step i) and the chitosan stock solution in step ii) such that the weight ratio of the nucleic acid and the chitosan is 20:1 to 10000:1, followed by stirring at 55-65° C. for 1-2 hours; and
iv) lowering the nucleic acid-chitosan mixture liquid in step iii) to room temperature with stirring.

### Claim 12 (depends on 10)

The method of claim 10, wherein the temperature-sensitive hydrogel composition has an osmotic pressure of 100-500 mOsm.

### Claim 13 (depends on 10)

The method of claim 10, wherein the temperature-sensitive hydrogel composition has a pH value of 6-8.
